153 related articles for article (PubMed ID: 28407749)
1. Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.
Xing X; Cai W; Ma S; Wang Y; Shi H; Li M; Jiao J; Yang Y; Liu L; Zhang X; Chen M
BMC Cancer; 2017 Apr; 17(1):268. PubMed ID: 28407749
[TBL] [Abstract][Full Text] [Related]
2. LINC00619 restricts gastric cancer progression by preventing microRNA-224-5p-mediated inhibition of OPCML.
Fang X; Dong Y; Yang R; Wei L
Arch Biochem Biophys; 2020 Aug; 689():108390. PubMed ID: 32359894
[TBL] [Abstract][Full Text] [Related]
3. Effect of OPCML gene on the biological behavior of gastric cancer cell line AGS.
Wang LH; Chu FF; Ren DH; Du XL
J Biol Regul Homeost Agents; 2016; 30(2):529-34. PubMed ID: 27358143
[TBL] [Abstract][Full Text] [Related]
4. Expression and promoter methylation status of OPCML and its functions in the inhibition of cell proliferation, migration, and invasion in breast cancer.
Lian B; Li H; Liu Y; Chai D; Gao Y; Zhang Y; Zhou J; Li J
Breast Cancer; 2021 Mar; 28(2):448-458. PubMed ID: 33108608
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic deregulations of Wnt/β-catenin and transforming growth factor beta-Smad pathways in esophageal cancer: Outcome of DNA methylation.
Singh V; Singh AP; Sharma I; Singh LC; Sharma J; Borthakar BB; Rai AK; Kataki AC; Kapur S; Saxena S
J Cancer Res Ther; 2019; 15(1):192-203. PubMed ID: 30880778
[TBL] [Abstract][Full Text] [Related]
6. SIK2 represses AKT/GSK3β/β-catenin signaling and suppresses gastric cancer by inhibiting autophagic degradation of protein phosphatases.
Dai XM; Zhang YH; Lin XH; Huang XX; Zhang Y; Xue CR; Chen WN; Ye JX; Lin XJ; Lin X
Mol Oncol; 2021 Jan; 15(1):228-245. PubMed ID: 33128264
[TBL] [Abstract][Full Text] [Related]
7. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.
Wang L; Zhu JS; Song MQ; Chen GQ; Chen JL
World J Gastroenterol; 2006 Nov; 12(43):6949-54. PubMed ID: 17109515
[TBL] [Abstract][Full Text] [Related]
8. Methylation of OPCML promoter in ovarian cancer tissues predicts poor patient survival.
Zhou F; Tao G; Chen X; Xie W; Liu M; Cao X
Clin Chem Lab Med; 2014 May; 52(5):735-42. PubMed ID: 24327526
[TBL] [Abstract][Full Text] [Related]
9. AEG-1 is a target of perifosine and is over-expressed in gastric dysplasia and cancers.
Huang W; Yang L; Liang S; Liu D; Chen X; Ma Z; Zhai S; Li P; Wang X
Dig Dis Sci; 2013 Oct; 58(10):2873-80. PubMed ID: 23912246
[TBL] [Abstract][Full Text] [Related]
10. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.
McKie AB; Vaughan S; Zanini E; Okon IS; Louis L; de Sousa C; Greene MI; Wang Q; Agarwal R; Shaposhnikov D; Wong JL; Gungor H; Janczar S; El-Bahrawy M; Lam EW; Chayen NE; Gabra H
Cancer Discov; 2012 Feb; 2(2):156-71. PubMed ID: 22585860
[TBL] [Abstract][Full Text] [Related]
11. Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.
Reed JE; Dunn JR; du Plessis DG; Shaw EJ; Reeves P; Gee AL; Warnke PC; Sellar GC; Moss DJ; Walker C
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):77-85. PubMed ID: 17239010
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of IC53d promotes the proliferation of gastric cancer cells by activating the AKT/GSK3β/cyclin D1 signaling pathway.
Lin JX; Xie XS; Weng XF; Qiu SL; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Li P; Huang CM; Zheng CH
Oncol Rep; 2019 May; 41(5):2739-2752. PubMed ID: 30864700
[TBL] [Abstract][Full Text] [Related]
13.
Khamko R; Daduang J; Settasatian C; Limpaiboon T
Cancer Genomics Proteomics; 2021; 18(6):771-780. PubMed ID: 34697068
[TBL] [Abstract][Full Text] [Related]
14. The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.
Antony J; Zanini E; Kelly Z; Tan TZ; Karali E; Alomary M; Jung Y; Nixon K; Cunnea P; Fotopoulou C; Paterson A; Roy-Nawathe S; Mills GB; Huang RY; Thiery JP; Gabra H; Recchi C
EMBO Rep; 2018 Aug; 19(8):. PubMed ID: 29907679
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1.
Xing S; Tian Z; Zheng W; Yang W; Du N; Gu Y; Yin J; Liu H; Jia X; Huang D; Liu W; Deng M
Mol Cancer; 2021 Jan; 20(1):9. PubMed ID: 33407516
[TBL] [Abstract][Full Text] [Related]
16. Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt.
Ye Y; Ge YM; Xiao MM; Guo LM; Li Q; Hao JQ; Da J; Hu WL; Zhang XD; Xu J; Zhang LJ
J Gastroenterol; 2016 Mar; 51(3):230-40. PubMed ID: 26201869
[TBL] [Abstract][Full Text] [Related]
17. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA UCA1 induced by SP1 promotes cell proliferation via recruiting EZH2 and activating AKT pathway in gastric cancer.
Wang ZQ; Cai Q; Hu L; He CY; Li JF; Quan ZW; Liu BY; Li C; Zhu ZG
Cell Death Dis; 2017 Jun; 8(6):e2839. PubMed ID: 28569779
[TBL] [Abstract][Full Text] [Related]
19. Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway.
Zhang Y; Chen P; Yin W; Ji Y; Shen Q; Ni Q
Hum Pathol; 2018 Feb; 72():107-116. PubMed ID: 29208564
[TBL] [Abstract][Full Text] [Related]
20. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer.
Chen DL; Zeng ZL; Yang J; Ren C; Wang DS; Wu WJ; Xu RH
J Hematol Oncol; 2013 Jun; 6():43. PubMed ID: 23806079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]